ERBB2 and neoplasm: Among all ovarian metastases, a higher frequency of HER2 positivity in ovarian metastases was correlated with peritoneal metastasis and bilateral ovarian metastasis (P < 0.05) but not with age, synchronous or metachronous ovarian metastases or primary tumour location (P > 0.05) (Table 4).